TickerFacts.

A business in context

ABT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-21 · 0001628280-26-066601 · Items 2.02,9.01

  2. 8-K · Current report

    Report date 2026-10-21 · 0001104659-26-117587 · Items 8.01,9.01

  3. 4 · Ownership change

    Report date 2026-09-30 · 0001104659-26-113291

  4. 4 · Ownership change

    Report date 2026-09-30 · 0001104659-26-113287

  5. 4 · Ownership change

    Report date 2026-09-30 · 0001104659-26-113286

  6. 4 · Ownership change

    Report date 2026-09-30 · 0001104659-26-113285

  7. 4 · Ownership change

    Report date 2026-09-30 · 0001104659-26-113280

  8. 4 · Ownership change

    Report date 2026-09-23 · 0001306119-26-000009

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001805099-26-000008

  10. 4 · Ownership change

    Report date 2026-09-01 · 0001644207-26-000012

  11. 8-K · Current report

    Report date 2026-08-20 · 0001104659-26-099247 · Items 7.01,8.01,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-050134

  13. 8-K · Current report

    Report date 2026-07-16 · 0001628280-26-048377 · Items 2.02,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028357

  15. 8-K · Current report

    Report date 2026-04-24 · 0001104659-26-049434 · Items 5.02,5.03,5.07,9.01

  16. 8-K · Current report

    Report date 2026-04-10 · 0001104659-26-044892 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-04-16 · 0001628280-26-025365 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-03-23 · 0001104659-26-033079 · Items 8.01,9.01

  19. DEF 14A · Proxy statement

    Report date 2026-04-24 · 0001308179-26-000064

  20. 8-K · Current report

    Report date 2026-03-09 · 0001104659-26-025240 · Items 1.01,2.03,9.01

  21. 8-K · Current report

    Report date 2026-02-23 · 0001104659-26-020509 · Items 1.01,9.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-010185

  23. 8-K · Current report

    Report date 2026-02-20 · 0001104659-26-018167 · Items 5.03,9.01

  24. 8-K · Current report

    Report date 2026-01-22 · 0001628280-26-002982 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-12-12 · 0001104659-25-120657 · Items 5.02,5.03,9.01

  26. 8-K · Current report

    Report date 2025-11-18 · 0001104659-25-114995 · Items 5.04,9.01

  27. 8-K · Current report

    Report date 2025-11-19 · 0001104659-25-114422 · Items 1.01,7.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-047131

  29. 8-K · Current report

    Report date 2025-10-15 · 0001628280-25-045049 · Items 2.02,9.01

  30. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-036720

  31. 8-K · Current report

    Report date 2025-07-17 · 0001628280-25-035135 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-04-25 · 0001104659-25-043508 · Items 5.02

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-021090

  34. 8-K · Current report

    Report date 2025-04-25 · 0001104659-25-040201 · Items 5.07

  35. 8-K · Current report

    Report date 2025-04-16 · 0001628280-25-017924 · Items 2.02,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0001308179-25-000134

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-007110

  38. 8-K · Current report

    Report date 2025-01-22 · 0001628280-25-002092 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-11-12 · 0001104659-24-119717 · Items 5.02

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-044602

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 5 transaction rows5AExercise / conversion: 4 transaction rows4MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

18 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-23
2026-09-25
Conroy Kevin TF · Tax / exercise payment
Disposed
Common shares without par value52507.0103.99
2026-09-02
2026-09-03
MCCOY JOHN A. JR.S · Sale
Disposed
Common shares without par value27.0109.54
2026-09-01
2026-09-03
Boudreau Philip PF · Tax / exercise payment
Disposed
Common shares without par value388.0110.36
2026-09-01
2026-09-03
MCCOY JOHN A. JR.F · Tax / exercise payment
Disposed
Common shares without par value52.0110.36
2026-08-25
2026-08-27
Ford Robert BM · Exercise / conversion
Acquired
Common shares without par value151869.044.4
2026-08-25
2026-08-27
Ford Robert BM · Exercise / conversion
Acquired
Common shares without par value246963.059.94
2026-08-25
2026-08-27
Ford Robert BS · Sale
Disposed
Common shares without par value218535.0115.57
2026-08-25
2026-08-27
Ford Robert BS · Sale
Disposed
Common shares without par value180297.0116.19
2026-08-25
2026-08-27
Ford Robert BM · Exercise / conversion
Disposed
Option (right to buy)
Derivative security
246963.00.0
2026-08-25
2026-08-27
Ford Robert BM · Exercise / conversion
Disposed
Option (right to buy)
Derivative security
151869.00.0
2026-08-12
2026-08-13
Morrone Louis H.I · Other (see filing)
Disposed
Common shares without par value12.0107.99
2026-08-11
2026-08-13
Morrone Louis H.S · Sale
Disposed
Common shares without par value5850.0109.83
2026-06-30
2026-07-01
Ahuja NitaA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
347.090.74
2026-06-30
2026-07-01
Gonzalez Patricia PaolaA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
363.090.74
2026-06-30
2026-07-01
Morrone Louis H.F · Tax / exercise payment
Disposed
Common shares without par value269.092.71
2026-06-30
2026-07-01
Roman Michael FA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
416.090.74
2026-06-30
2026-07-01
Stratton John GA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
432.090.74
2026-06-30
2026-07-01
Conroy Kevin TA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
231.090.74

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000001800ABBOTT LABORATORIES
Abbott SpainAbbott (Canada)Abbott JapanAbbott (South Korea)Abbott (Germany)Abbott LaboratoriesAbbott Rapid Diagnostics Jena GmbHAbbott (Chile)

Showing 8 of 8 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
HQD377W2YR662HK5JX27
GLEIF legal name
ABBOTT LABORATORIES
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-09-02T18:36:07Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Abbott Labs · alias · wikidata
  • Abbott Laboratories, Inc. · alias · wikidata
  • Ross Laboratories · alias · wikidata
  • Abbott Pharmaceuticals · alias · wikidata
  • Abbott Nutrition · alias · wikidata
  • I-STAT · alias · wikidata
  • Abbott Molecular · alias · wikidata
  • Isomil · alias · wikidata
  • Abbot Laboratories · alias · wikidata
  • Abbott · alias · wikidata
  • Abbott Spain · subsidiary · wikidata
  • Abbott (Canada) · subsidiary · wikidata
  • Abbott Japan · subsidiary · wikidata
  • Abbott (Japan) · subsidiary · wikidata
  • Dainabot · subsidiary · wikidata
  • Abbott (South Korea) · subsidiary · wikidata
  • Abbott (Germany) · subsidiary · wikidata
  • Abbott Laboratories · subsidiary · wikidata
  • Abbott (United Kingdom) · subsidiary · wikidata
  • Abbott Rapid Diagnostics Jena GmbH · subsidiary · wikidata
  • Abbott (Chile) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$41.95B$45.06B
2023-12-31$40.11B$44.35B
2022-12-31$43.65B$50.25B
2021-12-31$43.08B$53.55B
2020-12-31$34.61B$45.05B
2019-12-31$31.90B$42.04B
2018-12-31$30.58B$41.03B
2017-12-31$27.39B$37.65B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗